Answers are grounded in this paper and cite their sources.
show autoantibodies against Cl-INH with an ELISA method failed in all patients. Patients 1, 2 and 4 were treated with androgen derivatives. Patients 1 and 4 did not register any change in complement profile nor in symptoms. Patient 2 had disappearance of attacks, normalization of Cl-INH while Clq,r,s and C4 re mained undetectable. Cl-INH reverted to pathologi cal levels within 25 days after withdrawing the thera py. These data suggest the existence of differences in Cl-INH catabolism among acquired Cl-INH defi ciencies. Patient 2 shows that Cl-INH consumption follows Cl activation and that androgens may be effective while Cl hyperactivation persists.
No takes yet. Share an insight, caveat, or question.
A 2017 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: